A systematic approach to virus-virus interactions

Virus Research

Volumn 149, Issue 1, 2010, Pages 1-9

  DaPalma, T ^a   Doonan, B P ^a   Trager, N M ^a   Kasman, L M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Coinfection; Concurrent infection; Heterologous immunity; Viral pathology; Virus virus interaction

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ACICLOVIR; FAMCICLOVIR; GANCICLOVIR; GENE PRODUCT; INTERFERON; POLIOMYELITIS VACCINE; PRODRUG; PROTEIN KINASE R; VIRUS RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT ENHANCEMENT; AUTOIMMUNITY; CONCURRENT INFECTION; DISEASE PREDISPOSITION; DRUG ACTIVATION; EMBEDDING; ENTEROVIRUS INFECTION; GENETIC RECOMBINATION; HELPER VIRUS; HERPES VIRUS INFECTION; HETEROLOGOUS EXPRESSION; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MIXED INFECTION; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSEUDOTYPING; RETROVIRUS; REVIEW; SUPERINFECTION; TRANSACTIVATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

HELPER VIRUSES; VIRAL INTERFERENCE; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUS REPLICATION; VIRUSES;

EID: 77549084732     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.01.002     Document Type: Review

References (129)

1. Ackermann H.W., and Kropinski A.M. Curated list of prokaryotic viruses with fully sequenced genomes. Res. Microbiol. 158 7 (2007) 555-566
2. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 96 22 (1999) 12766-12771
3. Andreoletti L., Hober D., Hober-Vandenberghe C., Fajardy I., Belaich S., Lambert V., Vantyghem M.C., Lefebvre J., and Wattre P. Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin. Diagn. Virol. 9 2-3 (1998) 125-133
4. Arita M., Zhu S.L., Yoshida H., Yoneyama T., Miyamura T., and Shimizu H. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J. Virol. 79 20 (2005) 12650-12657
5. Atencio I.A., Belli B., Hobbs M., Cheng S.F., Villarreal L.P., and Fan H. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice. Virology 212 2 (1995) 356-366
6. Barrett A.D., and Gould E.A. Antibody-mediated early death in vivo after infection with yellow fever virus. J. Gen. Virol. 67 Pt 11 (1986) 2539-2542
7. Barrett K., Calendar R., Gibbs W., Goldstein R.N., Lindqvist B., and Six E. Helper-dependent bacteriophage P4: a model satellite virus and its implications for animal virology. Prog. Med. Virol. 15 (1973) 309-330
8. Bellec L., Grimsley N., and Desdevises Y. Isolation of prasinoviruses of the green unicellular algae Ostreococcus spp. on a worldwide geographical scale. Appl. Environ. Microbiol. 76 1 (2010) 96-101
9. Biancotto A., Iglehart S.J., Lisco A., Vanpouille C., Grivel J.C., Lurain N.S., Reichelderfer P.S., and Margolis L.B. Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo. AIDS Res. Hum. Retroviruses 24 3 (2008) 453-462
10. Brindley M.A., Zhang B., Montelaro R.C., and Maury W. An equine infectious anemia virus variant superinfects cells through novel receptor interactions. J. Virol. 82 19 (2008) 9425-9432
11. Budt M., Niederstadt L., Valchanova R.S., Jonjic S., and Brune W. Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. J. Virol. 83 3 (2009) 1260-1270
12. Buller R.M., Janik J.E., Sebring E.D., and Rose J.A. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J. Virol. 40 1 (1981) 241-247
13. Burke D.S. Recombination in HIV: an important viral evolutionary strategy. Emerg. Infect. Dis. 3 3 (1997) 253-259
14. Burke D.S., Nisalak A., Johnson D.E., and Scott R.M. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38 1 (1988) 172-180
15. Cassady K.A. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J. Virol. 79 14 (2005) 8707-8715
16. Celum C., Levine R., Weaver M., and Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull. World Health Organ. 82 6 (2004) 447-453
17. Celum C.L. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11 Suppl. 1 (2004) 36A-45A
18. Certo J.L., Shook B.F., Yin P.D., Snider J.T., and Hu W.S. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J. Virol. 72 7 (1998) 5408-5413
19. Chen H.D., Fraire A.E., Joris I., Brehm M.A., Welsh R.M., and Selin L.K. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2 11 (2001) 1067-1076
20. Chen H.D., Fraire A.E., Joris I., Welsh R.M., and Selin L.K. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am. J. Pathol. 163 4 (2003) 1341-1355
21. Chen T., and Hudnall S.D. Anatomical mapping of human herpesvirus reservoirs of infection. Mod. Pathol. 19 5 (2006) 726-737
22. Choi S.K., Yoon J.Y., Ryu K.H., Choi J.K., Palukaitis P., and Park W.M. Systemic movement of a movement-deficient strain of Cucumber mosaic virus in zucchini squash is facilitated by a cucurbit-infecting potyvirus. J. Gen. Virol. 83 Pt 12 (2002) 3173-3178
23. Chou S.W. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J. Infect. Dis. 160 1 (1989) 11-15
24. Christen U., Edelmann K.H., McGavern D.B., Wolfe T., Coon B., Teague M.K., Miller S.D., Oldstone M.B., and von Herrath M.G. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Invest. 114 9 (2004) 1290-1298
25. Clements G.B., Galbraith D.N., and Taylor K.W. Coxsackie B virus infection and onset of childhood diabetes. Lancet 346 8969 (1995) 221-223
26. Cummings D.A., Schwartz I.B., Billings L., Shaw L.B., and Burke D.S. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc. Natl. Acad. Sci. U.S.A. 102 42 (2005) 15259-15264
27. D'Alessio D.J. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am. J. Epidemiol. 135 12 (1992) 1331-1338
28. Dahlquist G.G., Ivarsson S., Lindberg B., and Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 44 4 (1995) 408-413
29. Diaz J.J., Dodon M.D., Schaerer-Uthurralt N., Simonin D., Kindbeiter K., Gazzolo L., and Madjar J.J. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature 379 6562 (1996) 273-277
30. Dorigo O., Gil J.S., Gallaher S.D., Tan B.T., Castro M.G., Lowenstein P.R., Calos M.P., and Berk A.J. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. J. Virol. 78 12 (2004) 6556-6566
31. Evans C.F., Horwitz M.S., Hobbs M.V., and Oldstone M.B. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. Med. 184 6 (1996) 2371-2384
32. Federico M., Bona R., D'Aloja P., Baiocchi M., Pugliese K., Nappi F., Chelucci C., Mavilio F., and Verani P. Anti-HIV viral interference induced by retroviral vectors expressing a no producer HIV-1 variant. Act Haematology. 95 3-4 (1996) 199-203
33. Flamand L., and Menezes J. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 70 3 (1996) 1784-1791
34. Flint VS., Inquest LAW., Racially VS., and Skulk A.M. Attachment and Entry, Principles of Virology. 2 ed. (2004), SAM Press, Washington, DC pp. 127-180
35. Friesen P.D., and Nissen M.S. Gene organization and transcription of TED, a lepidopteron retrotranspos on integrated within the baculovirus genome. Mol. Cell. Biol. 10 6 (1990) 3067-3077
36. Fujimura T., and Esteban R. Interactions of the RNA polymerase with the viral genome at the 5′- and 3′-ends contribute to the 20S RNA narnavirus persistence in yeast. J. Biol. Chem. 282 26 (2007) 19011-19019
37. Funke S., Schneider I.C., Glaser S., Muhlebach M.D., Moritz T., Cattaneo R., Cichutek K., and Buchholz C.J. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity. Gene Ther. 16 5 (2009) 700-705
38. Galligan C.L., Murooka T.T., Rahbar R., Baig E., Majchrzak-Kita B., and Fish E.N. Interferons and viruses: signaling for supremacy. Immunol. Res. 35 1-2 (2006) 27-40
39. Garcia M.A., Meurs E.F., and Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89 6-7 (2007) 799-811
40. Gardner I.D., and Shortridge K.F. Recombination as a mechanism in the evolution of influenza viruses: a two-year study of ducks in Hong Kong. Rev. Infect. Dis. 1 5 (1979) 885-890
41. Geib T., Sauder C., Venturelli S., Hassler C., Staeheli P., and Schwemmle M. Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J. Virol. 77 7 (2003) 4283-4290
42. Gifford R., and Tristem M. The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26 3 (2003) 291-315
43. Goncalves M.A. Adeno-associated virus: from defective virus to effective vector. Virol. J. 2 (2005) 43
44. Gould E.A., and Buckley A. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence. J. Gen. Virol. 70 Pt 6 (1989) 1605-1608
45. Grist N.R., Bell E.J., and Assaad F. Enteroviruses in human disease. Prog. Med. Virol. 24 (1978) 114-157
46. Grivel J.C., Ito Y., Faga G., Santoro F., Shaheen F., Malnati M.S., Fitzgerald W., Lusso P., and Margolis L. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat. Med. 7 11 (2001) 1232-1235
47. Haberland M., Meyer-Konig U., and Hufert F.T. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J. Gen. Virol. 80 Pt 6 (1999) 1495-1500
48. Habayeb M.S., Ekengren S.K., and Hultmark D. Nora virus, a persistent virus in Drosophila, defines a new picorna-like virus family. J. Gen. Virol. 87 Pt 10 (2006) 3045-3051
49. Halstead S.B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140 4 (1979) 527-533
50. Heng M.C., Heng S.Y., and Allen S.G. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343 8892 (1994) 255-258
51. Hengel H., Koszinowski U.H., and Conzelmann K.K. Viruses know it all: new insights into IFN networks. Trends Immunol. 26 7 (2005) 396-401
52. Hertig C., Coupar B.E., Gould A.R., and Boyle D.B. Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 235 2 (1997) 367-376
53. Hiltunen M., Hyoty H., Knip M., Ilonen J., Reijonen H., Vahasalo P., Roivainen M., Lonnrot M., Leinikki P., Hovi T., and Akerblom H.K. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J. Infect. Dis. 175 3 (1997) 554-560
54. Hsiao F.C., Lin M., Tai A., Chen G., and Huber B.T. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J. Immunol. 177 4 (2006) 2056-2060
55. Hsiao F.C., Tai A.K., Deglon A., Sutkowski N., Longnecker R., and Huber B.T. EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology 385 1 (2009) 261-266
56. Hyoty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T., et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44 6 (1995) 652-657
57. Iankov I.D., Pandey M., Harvey M., Griesmann G.E., Federspiel M.J., and Russell S.J. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J. Virol. 80 17 (2006) 8530-8540
58. Iwabu Y., Mizuta H., Kawase M., Kameoka M., Goto T., and Ikuta K. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect. 10 5 (2008) 504-513
59. Juhela S., Hyoty H., Lonnrot M., Roivainen M., Simell O., and Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J. Med. Virol. 54 3 (1998) 226-232
60. Juhela S., Hyoty H., Uibo R., Meriste S.H., Uibo O., Lonnrot M., Halminen M., Simell O., and Ilonen J. Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines. Clin. Exp. Immunol. 117 1 (1999) 100-105
61. Kacprzak-Bergman I., and Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch. Immunol. Ther. Exp. (Warsz) 53 2 (2005) 139-142
62. Kenyon L., Lebas B.S., and Seal S.E. Yams (Dioscorea spp.) from the South Pacific Islands contain many novel badnaviruses: implications for international movement of yam germplasm. Arch. Virol. 153 5 (2008) 877-889
63. Kim S., Yu S.S., and Kim V.N. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein. J. Gen. Virol. 77 Pt 1 (1996) 83-91
64. Kliem M., and Dreiseikelmann B. The superimmunity gene sim of bacteriophage P1 causes superinfection exclusion. Virology 171 2 (1989) 350-355
65. Kliks S.C., Nimmanitya S., Nisalak A., and Burke D.S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38 2 (1988) 411-419
66. Kliks S.C., Nisalak A., Brandt W.E., Wahl L., and Burke D.S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40 4 (1989) 444-451
67. Kwun H.J., Han H.J., Lee W.J., Kim H.S., and Jang K.L. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res. 86 1-2 (2002) 93-100
68. Lalle E., Sacchi A., Abbate I., Vitale A., Martini F., D'Offizi G., Antonucci G., Castilletti C., Poccia F., and Capobianchi M.R. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int. J. Immunopathol. Pharmacol. 21 1 (2008) 161-171
69. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119 1 (2006) 100-110
70. Lee A.H., Lee K.J., Kim S., and Sung Y.C. Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence. J. Virol. 66 5 (1992) 3236-3240
71. Levin S., and Hahn T. Interferon deficiency syndrome. Clin. Exp. Immunol. 60 2 (1985) 267-273
72. Levy D.E., and Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12 2-3 (2001) 143-156
73. Li D., Duan L., Freimuth P., and O'Malley Jr. B.W. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin. Cancer Res. 5 12 (1999) 4175-4181
74. Li Y., Ye J., Cao S., Xiao S., Zhao Q., Liu X., Jin M., and Chen H. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. J. Gene Med. 11 1 (2009) 57-65
75. Lisco A., Grivel J.C., Biancotto A., Vanpouille C., Origgi F., Malnati M.S., Schols D., Lusso P., and Margolis L.B. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J. Virol. 81 2 (2007) 708-717
76. Lisco A., Vanpouille C., and Margolis L. Coinfecting viruses as determinants of HIV disease. Curr. HIV/AIDS Rep. 6 1 (2009) 5-12
77. Lisco A., Vanpouille C., Tchesnokov E.P., Grivel J.C., Biancotto A., Brichacek B., Elliott J., Fromentin E., Shattock R., Anton P., Gorelick R., Balzarini J., McGuigan C., Derudas M., Gotte M., Schinazi R.F., and Margolis L. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe 4 3 (2008) 260-270
78. Lusso P., De Maria A., Malnati M., Lori F., DeRocco S.E., Baseler M., and Gallo R.C. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature 349 6309 (1991) 533-535
79. Lusso P., Secchiero P., Crowley R.W., Garzino-Demo A., Berneman Z.N., and Gallo R.C. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 91 9 (1994) 3872-3876
80. Marconi P., Argnani R., Berto E., Epstein A.L., and Manservigi R. HSV as a vector in vaccine development and gene therapy. Hum. Vaccin. 4 2 (2008) 91-105
81. Marques R., Antunes I., Eksmond U., Stoye J., Hasenkrug K., and Kassiotis G. B lymphocyte activation by coinfection prevents immune control of friend virus infection. J. Immunol. 181 5 (2008) 3432-3440
82. McAllister W.T., and Barrett C.L. Superinfection exclusion by bacteriophage T7. J. Virol. 24 2 (1977) 709-711
83. Melcher U. The '30K' superfamily of viral movement proteins. J. Gen. Virol. 81 Pt 1 (2000) 257-266
84. Meyers C., Mane M., Kokorina N., Alam S., and Hermonat P.L. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 272 2 (2000) 338-346
85. Nelson M.I., Viboud C., Simonsen L., Bennett R.T., Griesemer S.B., St George K., Taylor J., Spiro D.J., Sengamalay N.A., Ghedin E., Taubenberger J.K., and Holmes E.C. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4 2 (2008) e1000012
86. Nethe M., Berkhout B., and van der Kuyl A.C. Retroviral superinfection resistance. Retrovirology 2 (2005) 52
87. Nogawa M., Kageyama T., Nakatani A., Taguchi G., Shimosaka M., and Okazaki M. Cloning and characterization of mycovirus double-stranded RNA from the plant pathogenic fungus, Fusarium solani f. sp. robiniae. Biosci. Biotechnol. Biochem. 60 5 (1993) 784-788
88. Nuzzo J.B., and Lam C. WHO issues draft protocol for containing and influenza pandemic. Biosecur. Bioterror. 4 2 (2006) 93-95
89. Ogawa T., Sharma P., and Ikegami M. The begomoviruses Honeysuckle yellow vein mosaic virus and Tobacco leaf curl Japan virus with DNAβ satellites cause yellow dwarf disease of tomato. Virus Res. 137 2 (2008) 235-244
90. Pancharoen C., Mekmullica J., Chinratanapisit S., Bhattarakosol P., and Thisyakorn U. Seroprevalence of Epstein-Barr virus antibody among children in various age groups in Bangkok, Thailand. Asian Pac. J. Allergy Immunol. 19 2 (2001) 135-137
91. Peiris J.S., and Porterfield J.S. Antibody-mediated enhancement of flavivirus replication in macrophage-like cell lines. Nature 282 5738 (1979) 509-511
92. Ponnuraj E.M., Springer J., Hayward A.R., Wilson H., and Simoes E.A. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J. Infect. Dis. 187 8 (2003) 1257-1263
93. Poole L.J., Zong J.C., Ciufo D.M., Alcendor D.J., Cannon J.S., Ambinder R., Orenstein J.M., Reitz M.S., and Hayward G.S. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J. Virol. 73 8 (1999) 6646-6660
94. Porter D.D., Larsen A.E., and Porter H.G. The pathogenesis of Aleutian disease of mink. II. Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody. J. Immunol. 109 1 (1972) 1-7
95. Pospisek M., Palkova Z., Janderova B., and Korb J. Isolation and characterization of the dsRNA virus from the yeast Endomyces magnusii. FEMS Microbiol. Lett. 116 2 (1994) 231-236
96. Prabhakar B.S., and Nathanson N. Acute rabies death mediated by antibody. Nature 290 5807 (1981) 590-591
97. Rakoto-Andrianarivelo M., Gumede N., Jegouic S., Balanant J., Andriamamonjy S.N., Rabemanantsoa S., Birmingham M., Randriamanalina B., Nkolomoni L., Venter M., Schoub B.D., Delpeyroux F., and Reynes J.M. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J. Infect. Dis. 197 10 (2008) 1427-1435
98. Randazzo B.P., Tal-Singer R., Zabolotny J.M., Kesari S., and Fraser N.W. Herpes simplex virus 1716, an ICP 34.5 null mutant, is unable to replicate in CV-1 cells due to a translational block that can be overcome by coinfection with SV40. J. Gen. Virol. 78 Pt 12 (1997) 3333-3339
99. Rizzetto M. Hepatitis D: thirty years after. J. Hepatol. 50 5 (2009) 1043-1050
100. Robertson H.D., Manche L., and Mathews M.B. Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR. J. Virol. 70 8 (1996) 5611-5617
101. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., and Halstead S.B. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120 5 (1984) 653-669
102. Saumet A., and Lecellier C.H. Anti-viral RNA silencing: do we look like plants?. Retrovirology 3 (2006) 3
103. Schwarze-Zander C., Blackard J.T., Zheng H., Addo M.M., Lin W., Robbins G.K., Sherman K.E., Zdunek D., Hess G., and Chung R.T. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J. Infect. Dis. 194 4 (2006) 410-419
104. Selin L.K., Vergilis K., Welsh R.M., and Nahill S.R. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183 6 (1996) 2489-2499
105. Shah A.C., Parker J.N., Gillespie G.Y., Lakeman F.D., Meleth S., Markert J.M., and Cassady K.A. Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. Gene Ther. 14 13 (2007) 1045-1054
106. Sheffield J.S., Wendel Jr. G.D., McIntire D.D., and Norgard M.V. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J. Infect. Dis. 196 10 (2007) 1509-1516
107. Shore D., Deho G., Tsipis J., and Goldstein R. Determination of capsid size by satellite bacteriophage P4. Proc. Natl. Acad. Sci. U.S.A. 75 1 (1978) 400-404
108. Six E.W., and Klug C.A. Bacteriophage P4: a satellite virus depending on a helper such as prophage P2. Virology 51 2 (1973) 327-344
109. Snyder J.C., Stedman K., Rice G., Wiedenheft B., Spuhler J., and Young M.J. Viruses of hyperthermophilic Archaea. Res. Microbiolog. 154 7 (2003) 474-482
110. Staeheli P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38 (1990) 147-200
111. Streeck H., Li B., Poon A.F., Schneidewind A., Gladden A.D., Power K.A., Daskalakis D., Bazner S., Zuniga R., Brander C., Rosenberg E.S., Frost S.D., Altfeld M., and Allen T.M. Immune-driven recombination and loss of control after HIV superinfection. J. Exp. Med. 205 8 (2008) 1789-1796
112. Sugawara Y., Makuuchi M., Kato N., Shimotohno K., and Takada K. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. EMBO J. 18 20 (1999) 5755-5760
113. Takada A., and Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 13 6 (2003) 387-398
114. Timpe J.M., Verrill K.C., and Trempe J.P. Effects of adeno-associated virus on adenovirus replication and gene expression during coinfection. J. Virol. 80 16 (2006) 7807-7815
115. Toth F.D., Aboagye-Mathiesen G., Szabo J., Liu X., Mosborg-Petersen P., Kiss J., Hager H., Zdravkovic M., Andirko I., Aranyosi J., et al. Bidirectional enhancing activities between human T cell leukemia-lymphoma virus type I and human cytomegalovirus in human term syncytiotrophoblast cells cultured in vitro. AIDS Res. Hum. Retroviruses 11 12 (1995) 1495-1507
116. Trammell R.A., and Toth L.A. Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev. Mol. Diagn. 8 4 (2008) 515-529
117. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74 8 (2000) 3715-3730
118. Twu J.S., Rosen C.A., Haseltine W.A., and Robinson W.S. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J. Virol. 63 6 (1989) 2857-2860
119. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 1 (2000) 2-9
120. Wang J., Meers J., Spradbrow P.B., and Robinson W.F. Evaluation of immune effects of fowlpox vaccine strains and field isolates. Vet. Microbiol. 116 1-3 (2006) 106-119
121. Waterhouse P.M., and Murant A.F. Further evidence on the nature of the dependence of carrot mottle virus on carrot red leaf virus for transmission by aphids. Ann. Appl. Biol. 103 3 (2008) 455-464
122. Welsh R.M., and Fujinami R.S. Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 5 7 (2007) 555-563
123. Welsh R.M., Kim S.K., Cornberg M., Clute S.C., Selin L.K., and Naumov Y.N. The privacy of T cell memory to viruses. Curr. Top. Microbiol. Immunol. 311 (2006) 117-153
124. Welsh R.M., and Selin L.K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2 6 (2002) 417-426
125. Welsh R.M., Selin L.K., and Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu. Rev. Immunol. 22 (2004) 711-743
126. Wu Q., Fang L., Wu X., Li B., Luo R., Yu Z., Jin M., Chen H., and Xiao S. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Mol. Immunol. 46 11-12 (2009) 2210-2217
127. Yalkinoglu A.O., Heilbronn R., Burkle A., Schlehofer J.R., and zur Hausen H. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 48 11 (1988) 3123-3129
128. Yurochko A.D., Huong S.M., and Huang E.S. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation. J. Hum. Virol. 2 2 (1999) 81-90
129. Zavada J. Viral pseudotypes and phenotypic mixing. Arch. Virol. 50 1-2 (1976) 1-15